Announcements Trials
Browse Landscape

Phase

Phase NA 34Phase 3 4Phase 2 3Phase 4 1Phase 2/3 1

Status

Completed 4Active not recruiting 2Unknown 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 4Adenoma 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Completed × Colonoscopy × Clear all
NCT00032344 2018-08-31

Long-term Follow-up Study Designed to Evaluate the Relative Risk of Two Colonoscopy Schedules for Patients With Small Polyps

VA Office of Research and Development

Phase 3 Completed
3,200 enrolled
Gastrointestinal

Adenoma, Colorectal Neoplasms

NCT01075633 2014-01-08

COLONFAM

Fundación Canaria Rafael Clavijo para la Investigación Biomédica

Phase 3 Completed
1,501 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01251666 2012-09-03

HeMO

University Hospital, Caen

Phase 3 Completed
19,797 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01399710 2011-07-22

CAD-IMPACT

im3D S.p.A.

Phase 3 Completed
651 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡